IDP Pharma closes a funding round for 2 million euros Blog Post

IDP Pharma, founded in 2015 and with headquarters at the Barcelona Science Park (PCB) has raised, during its first operative year, over 2 million euros from public and private capital. The biopharmaceutical company –specializes in the development of drugs for cancer treatment directed to a new class of therapeutic targets: IDPs– will appoint this capital to continue the preclinical development of their most advanced products: two first-in-class molecules with antitumor activity for Multiple Myeloma, the second most common blood cancer

 

Mind the Byte launches six new software to accelerate drug discovery Blog Post

In line with the ground-breaking pay-per-use philosophy, Mind the Byte has launched six new programs for computational drug design on their SaaS platform (Software as a Service), which the company has been marketing since 2011. The new software expands the services currently on offer and helps cut drug-development time and costs up to 30% for companies and researchers. The products were launched at prices that adapt to the needs of each user.

 

A bridge towards new business opportunities in Korea Blog Post

Pharmaphenix –based at the Barcelona Science Park specializing in business development in emergent markets in Latin American and Korea with increasing activity in the Spanish market– has taken part one more year at BIO Korea, the largest partnering conference of the biotech, pharmaceutical and innovation sector in Asia. For three days, the pharmaceutical consultancy firm- with headquarters in Barcelona and in Seoul, South Korea– has intensified its contacts with key actors of the national bio-health sector to consolidate itself as a benchmark partner in the region. 

 

How tissue stiffness activates cancer Blog Post

Researchers at IBEC and their collaborators at the Georgia Institute of Technology  (Georgia Tech), publishing today in Nature Cell Biology, have identified the mechanism by which tissue stiffness activates a protein called YAP, a major oncogene. The new knowledge could potentially lead to new strategies to impair or even halt the growth of tumours.

 

The fair “Live Research” takes off at CosmoCaixa Blog Post

Bringing science to society, fostering communication between the public and researchers and promote scientific vocation among the young are the aims of the Live Research fair, that started yesterday at CosmoCaixa Barcelona until Saturday 9th April. The exhibit has been organized by the Barcelona Science Park (PCB) and Obra Social ”la Caixa” with the support of the Barcelona City Council and the collaboration of the University of Barcelona (UB).

 

9th Awards of the UB Board of Trustees and the Bosch i Gimpera Foundation Blog Post

The Board of Trustees of the University of Barcelona and the Bosch i Gimpera Foundation, locat at PCB, announce the 9th Awards of the Board of Trustees and the Bosch i Gimpera Foundation. They announced two awards: the Antoni Caparrós Award, to the best project of transferring knowledge, and the Senén Vilaró Award, to the best innovative firm created by a UB graduate or affiliated with the UB Group. The deadline for applications is 31 May.

 

2016 season of Lessons Learned kicks off Blog Post

Biocat and the CataloniaBio business association are holding the first session in the 2016 season of Lessons Learned on 31 March at the Barcelona Science Park. Experts and professionals from the health and life sciences sector will participate in a session entitled: ‘Models organitzatius a les bio-empreses i la gestió del canvi: Quines són les claus de l’èxit?’ discussing the doubts that come up in moving forward with projects from the biotechnology and pharmaceutical arenas.

 

Catalan biotech sector to meet in Stockholm Blog Post

The sixteenth edition of the BIO-Europe Spring (BES), the main springtime partnering conference of the sector, takes place this year in Stockholm from 4th to 6th April. The Catalan delegation, coordinated by Biocat once again, will be formed by 24 companies and entities –among which are the companies BioingeniumEsteveIntelligent Pharma and Iproteos, based at the Barcelona Science Park (PCB)–, representing more than a half of the Spanish participation at the event.